Diablo Clinical Research

Walnut Creek, California 94598-3347

7 studies enrolling now · 100 studies all time

What they study most

Acute Migraine, Analytical Performance of Sodium, Glucose and Hematocrit Assays by the i-STAT 500 (Alinity) Analyzer, Atherosclerotic Cardiovascular Disease, Autoimmune Diseases, Blood Pressure, Cardiovascular Disease, Cardiovascular Risk Factor, Celiac, Celiac Disease, Depression, Diabete Mellitus, Diabetes

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM — Recruiting now
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight — Completed
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight — Completed
• Biolinq Safety and Effectiveness Trial — Completed
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus — Completed
• Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial — Completed
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy — Completed
• A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus — Running, not enrolling
• Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home — Completed
• Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab — Completed
• SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes — Withdrawn before enrolling
• Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM — Completed
• Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System — Completed
• Using Signos mHealth Platform in Adults for Weight Management — Running, not enrolling
• PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days — Completed
• Assessment of KAN-101 in Celiac Disease (ACeD) — Completed
• Navigator 1.5 Accuracy Study — Completed
• PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm — Completed
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight — Completed
• A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus — Stopped early
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed
• Afrezza® Dosing Optimization Study — Completed
• Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults — Completed
• Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus — Completed
• Feasibility Studies of Personalized Closed Loop — Completed
• A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis — Completed
• VL-3 Training Study — Completed
• Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System — Completed
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
• A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee — Completed
• Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids — Completed
• Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics — Completed
• Insulet Artificial Pancreas Early Feasibility Study — Completed
• Dermal Cryotherapy for Treatment of Pigmented Lesions — Completed
• Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo — Stopped early
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
• G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes — Completed
• Study of DA-9801 to Treat Diabetic Neuropathy — Completed
• Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System — Completed
• A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1 — Completed
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early